{"name":"Xadcera Biopharmaceutical (Suzhou) Co., Ltd.","slug":"xadcera-biopharmaceutical-suzhou-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPbGQ2ZjVkM3RPV0RkbTdVbnhHMnlVMlpoaDk2dVlBZVJ6ZFhCWWFURWJvbHVfV1A4cjRkR3UwNXV4SGZ5Yl9nRV9XZ0hYVW1sM3dqZHlVNGV3S1hHRXZlZTV3UVZlTnlHbEZ3RjItdnYyRWZLNkVkM0RzTURyRktoemJnbUxyNW1zamtySmFhZXVlTER4UDRoRjI0Yno?oc=5","date":"2026-03-18","type":"trial","source":"openPR.com","summary":"Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+ - openPR.com","headline":"Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNRjQ3VUh4R0ZtbmdYQmJiNDFOSm03MXFtYXl3dG9OWV9sdlNvRlEyWXBhUmxzN3VGWktRWktnQ05tUm1RSDNBSk1mZGgzTlJSMk1kMWxYelNXUE1VdDg2WGlieE8zYzE5Sl9KWHJXYlo5N2dtTUJaWDlrMkdOeFB3ckEzeEN5V2hZNlFvTktxMDNBamFjRFdKZWtramdlR0t0T2FCQmc2OGJiSGJhZGpDdlBkNUVFcWJ2eDV4WksyOGEtQVVSbm1HWEt5WXZ1V29YTDlQTjB4d3JaUnZMOEV3ajg0U1FKTGNHdVc2aFNHWldFYXF0NTlQeWlsajJqWHJPX3NOQU8zVUdEazRUaDFBdlRGLVdYclpZSGdldWY4aWR6dw?oc=5","date":"2025-11-06","type":"trial","source":"prnewswire.com","summary":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight - prnewswire.com","headline":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immuno","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOaW4zU0poVnpIb2JTODhiOEZ0a1IxRGtKYlhnMDhQelF3eU92RVRDdGdockRkYXQ5MDJLeHAzZzdEVEdhajB5dlg3UWxBanlxTkUyU2JLUWZ2TnBrNkkyMENsOWJKeE1MeHd0YVhfM2lqTTM2dERYV01SdHp0aWZWUlV5MFdlOEpDOVE3aUVTcTdNQQ?oc=5","date":"2025-07-15","type":"trial","source":"Yahoo Finance","summary":"Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - Yahoo Finance","headline":"Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}